Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

نویسندگان

  • Valery L Feigin
  • Amanuel Alemu Abajobir
  • Kalkidan Hassen Abate
  • Foad Abd-Allah
  • Abdishakur M Abdulle
  • Semaw Ferede Abera
  • Gebre Yitayih Abyu
  • Muktar Beshir Ahmed
  • Amani Nidhal Aichour
  • Ibtihel Aichour
  • Miloud Taki Eddine Aichour
  • Rufus Olusola Akinyemi
  • Samer Alabed
  • Rajaa Al-Raddadi
  • Nelson Alvis-Guzman
  • Azmeraw T. Amare
  • Hossein Ansari
  • Palwasha Anwari
  • Johan Ärnlöv
  • Hamid Asayesh
  • Solomon Weldegebreal Asgedom
  • Tesfay Mehari Atey
  • Leticia Avila-Burgos
  • Euripide Frinel
  • G. Arthur Avokpaho
  • Aleksandra Barac
  • Miguel Barboza
  • Suzanne L Barker-Collo
  • Till Bärnighausen
  • Neeraj Bedi
  • Ettore Beghi
  • Derrick A Bennett
  • Isabela M Bensenor
  • Adugnaw Berhane
  • Balem Demtsu Betsu
  • Soumyadeep Bhaumik
  • Sait Mentes Birlik
  • Stan Biryukov
  • Dube Jara Boneya
  • Lemma Negesa Bulto Bulto
  • Hélène Carabin
  • Daniel Casey
  • Carlos A. Castañeda-Orjuela
  • Ferrán Catalá-López
  • Honglei Chen
  • Abdulaal A Chitheer
  • Rajiv Chowdhury
  • Hanne Christensen
  • Lalit Dandona
  • Rakhi Dandona
  • Gabrielle A de Veber
  • Samath D Dharmaratne
  • Huyen Phuc Do
  • Klara Dokova
  • E Ray Dorsey
  • Richard G Ellenbogen
  • Sharareh Eskandarieh
  • Maryam S Farvid
  • Seyed-Mohammad Fereshtehnejad
  • Florian Fischer
  • Kyle J Foreman
  • Johanna M Geleijnse
  • Richard F Gillum
  • Giorgia Giussani
  • Philimon N Gona
  • Alessandra Carvalho Goulart
  • Harish Chander Gugnani
  • Rahul Gupta
  • Rajeev Gupta
  • Randah Ribhi Hamadeh
  • Mitiku Hambisa
  • Graeme J Hankey
  • Habtamu Abera Hareri
  • Rasmus Havmoeller
  • Simon I Hay
  • Pouria Heydarpour
  • Peter J Hotez
  • Mihajlo (Michael) B Jakovljevic
  • Mehdi Javanbakht
  • Panniyammakal Jeemon
  • Jost B Jonas
  • Yogeshwar Kalkonde
  • Amit Kandel
  • André Karch
  • Amir Kasaeian
  • Anshul Kastor
  • Peter Njenga Keiyoro
  • Yousef Saleh Khader
  • Ibrahim A Khalil
  • Ejaz Ahmad Khan
  • Young-Ho Khang
  • Abdullah Tawfih
  • Abdullah Khoja
  • Jagdish Khubchandani
  • Daniel Kim
  • Yun Jin Kim
  • Mika Kivimaki
  • Yoshihiro Kokubo
  • Soewarta Kosen
  • Michael Kravchenko
  • Rita Vanmala Krishnamurthi
  • Barthelemy Kuate Defo
  • G Anil Kumar
  • Rashmi Kumar
  • Hmwe H Kyu
  • Anders Larsson
  • Pablo M Lavados
  • Yongmei Li
  • Xiaofeng Liang
  • Misgan Legesse Liben
  • Warren D Lo
  • Giancarlo Logroscino
  • Paulo A Lotufo
  • Clement T Loy
  • Mark T Mackay
  • Hassan Magdy Abd El Razek
  • Mohammed Magdy Abd El Razek
  • Azeem Majeed
  • Reza Malekzadeh
  • Treh Manhertz
  • Lorenzo G Mantovani
  • João Massano
  • Mohsen Mazidi
  • Colm McAlinden
  • Suresh Mehata
  • Man Mohan Mehndiratta
  • Ziad A Memish
  • Walter Mendoza
  • Mubarek Abera Mengistie
  • George A Mensah
  • Atte Meretoja
  • Haftay Berhane Mezgebe
  • Ted R Miller
  • Shiva Raj Mishra
  • Norlinah Mohamed Ibrahim
  • Alireza Mohammadi
  • Kedir Endris Mohammed
  • Shafiu Mohammed
  • Ali H Mokdad
  • Maziar Moradi-Lakeh
  • Ilais Moreno Velasquez
  • Kamarul Imran Musa
  • Mohsen Naghavi
  • Josephine Wanjiku Ngunjiri
  • Cuong Tat Nguyen
  • Grant Nguyen
  • Quyen Le Nguyen
  • Trang Huyen Nguyen
  • Emma Nichols
  • Dina Nur Anggraini Ningrum
  • Vuong Minh Nong
  • Bo Norrving
  • Jean Jacques N Noubiap
  • Felix Akpojene Ogbo
  • Mayowa O Owolabi
  • Jeyaraj D. Pandian
  • Max Petzold
  • Michael Robert Phillips
  • Michael A Piradov
  • Richie G. Poulton
  • Farshad Pourmalek
  • Mostafa Qorbani
  • Anwar Rafay
  • Mahfuzar Rahman
  • Mohammad HifzUr Rahman
  • Rajesh Kumar Rai
  • Sasa Rajsic
  • Annemarei Ranta
  • Salman Rawaf
  • Andre M.N. Renzaho
  • Mohammad Sadegh Rezai
  • Gholamreza Roshandel
  • Enrico Rubagotti
  • Perminder Sachdev
  • Saeid Safiri
  • Ramesh Sahathevan
  • Mohammad Ali Sahraian
  • Abdallah M. Samy
  • Paula Santalucia
  • Itamar S Santos
  • Benn Sartorius
  • Maheswar Satpathy
  • Monika Sawhney
  • Mete I Saylan
  • Sadaf G Sepanlou
  • Masood Ali Shaikh
  • Raad Shakir
  • Morteza Shamsizadeh
  • Kevin N Sheth
  • Mika Shigematsu
  • Haitham Shoman
  • Diego Augusto Santos Silva
  • Mari Smith
  • Eugene Sobngwi
  • Luciano A Sposato
  • Dan J Stein
  • Timothy J Steiner
  • Lars Jacob Stovner
  • Rizwan Suliankatchi Abdulkader
  • Cassandra EI Szoeke
  • Rafael Tabarés-Seisdedos
  • David Tanne
  • Alice M Theadom
  • Amanda G Thrift
  • David L Tirschwell
  • Roman Topor-Madry
  • Bach Xuan Tran
  • Thomas Truelsen
  • Kald Beshir Tuem
  • Kingsley Nnanna Ukwaja
  • Olalekan A Uthman
  • Yuri Y Varakin
  • Tommi Vasankari
  • Narayanaswamy Venketasubramanian
  • Vasiliy Victorovich Vlassov
  • Fiseha Wadilo
  • Tolassa Wakayo
  • Mitchell T Wallin
  • Elisabete Weiderpass
  • Ronny Westerman
  • Tissa Wijeratne
  • Charles Shey Wiysonge
  • Minyahil Alebachew Woldu
  • Charles D A Wolfe
  • Denis Xavier
  • Gelin Xu
  • Yuichiro Yano
  • Hassen Hamid Yimam
  • Naohiro Yonemoto
  • Chuanhua Yu
  • Zoubida Zaidi
  • Maysaa El Sayed Zaki
  • Joseph R Zunt
  • Christopher J L Murray
  • Theo Vos
چکیده

BACKGROUND Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level. METHODS We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development. FINDINGS Neurological disorders ranked as the leading cause group of DALYs in 2015 (250·7 [95% uncertainty interval (UI) 229·1 to 274·7] million, comprising 10·2% of global DALYs) and the second-leading cause group of deaths (9·4 [9·1 to 9·7] million], comprising 16·8% of global deaths). The most prevalent neurological disorders were tension-type headache (1505·9 [UI 1337·3 to 1681·6 million cases]), migraine (958·8 [872·1 to 1055·6] million), medication overuse headache (58·5 [50·8 to 67·4 million]), and Alzheimer's disease and other dementias (46·0 [40·2 to 52·7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36·7%, and the number of DALYs by 7·4%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26·1% and 29·7%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs. INTERPRETATION Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services. FUNDING Bill & Melinda Gates Foundation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Citation: Karikari TK, Charway-Felli A, Höglund K, Blennow K and Zetterberg H (2018) Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Front. Neurol. 9:201. doi: 10.3389/fneur.2018.00201 Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a sys...

متن کامل

Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies

Background: Iran is located in Asian esophageal cancer belt, with age-standardized incidence rate (ASR) of approximately 7 per 100,000 for both men and women. To provide potential solution recommendations for achieving accurate estimations regarding the burden of the disease in Iran, we designed a study to assess the burden of esophageal cancer in Iran during 1995-2015 by collecting data from t...

متن کامل

Burden of Disease Attributable to Suboptimal Breastfeeding in Iran during 1990-2010; Findings from the Global Burden of Disease Study 2010

Background: This study uses data of the global burden of diseases (GBD) study 2010 to report death, disability-adjusted life year (DALYs), years of life lived with disability (YLDs) and years of life lost due to premature mortality (YLLs), attributed to suboptimal breastfeeding by age and gender during 1990 to 2010 in Iran. Materials and Methods:The GBD assessments were used, together with esti...

متن کامل

Commentary: Estimates of Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoeal Diseases: A Systematic Analysis for the Global Burden of Disease Study 2015

Citation: Abdoli A and Maspi N (2018) Commentary: Estimates of Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoeal Diseases: A Systematic Analysis for the Global Burden of Disease Study 2015. Front. Med. 5:11. doi: 10.3389/fmed.2018.00011 Commentary: estimates of Global, regional, and national morbidity, mortality, and aetiologies of Diarrhoeal Diseases: a Systema...

متن کامل

Burden of Mental Disorders: A Study of the Middle East Countries for the Period 2000- 2017

Background: Mental disorders, as the most important global health challenge these days, have created many concerns for health systems, health professionals and policy makers and are a major contributor to the growth of health complications and disabilities worldwide. The present study was designed and conducted to describe the status of the illness burden of mental disorders in the Middle Easte...

متن کامل

ملاحظات اخلاقی

One of the most important summary measures of population health, is Disability Adjusted Life Years (DALY), introduced for the first time in the project of Global Burden of Disease (GBD), that is the newest as well as the most accepted and familial summary measure of health and the burden of diseases has been measured by this measure at national and regional levels in many countries of the world...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 16  شماره 

صفحات  -

تاریخ انتشار 2017